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Abstract

Background: In the United States, blood transfusions are the most common medical procedure
performed in hospitals. When used appropriately, allogeneic blood transfusions are crucial lifesaving interventions essential in perioperative management. The use of blood transfusions should
be based on safety, efficacy, and quality of treatment. However, a significant volume of evidence
has emerged correlating blood transfusions to adverse patient outcomes, increases in cost,
increases in morbidity, and mortality in surgical patients. Noting this, current transfusion
practices require further evaluation. Patient Blood Management is a novel multidisciplinary
approach that mitigate these negative outcomes.
Methods: A comprehensive literature search was conducted using CINAHL and MEDLINE
databases to identify research studies from 2015 and forward that have evaluated the
effectiveness of Patient Blood Management in reducing morbidity, mortality, and excess costs
associated with inappropriate allogeneic blood transfusion administration.
Results: A total of 8 research studies were identified for review. These studies analyzed various
treatment modalities within Patient Blood Management. The articles affirm the reliability and
validity of the initiative in reducing the overutilization allogeneic blood transfusions in the
perioperative period and thus reducing the associated adverse outcomes and cost.

Keywords: Patient Blood Management, blood transfusions, restrictive transfusion practices.
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transfusion practices.
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Introduction
Blood transfusions are overprescribed in elective surgeries.1–5 They are one of the most
ubiquitous medical interventions utilized in modern medicine, and their use is ingrained into
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medical practice. This has resulted in allogeneic blood transfusions becoming a mainstay
treatment in the perioperative period to treat a variety of pathologies to aid in maintaining a
patient's optimal cardiopulmonary status. There is an apparent lack of guidelines for ordering
blood transfusions during the perioperative period, which has resulted in its overuse.1 It is
estimated that in the United States of America, 1 in 7 hospitalized patients has received a blood
transfusion, totaling 30 million units of blood transfused per year.4 A growing consensus affirms
that blood transfusions are overutilized and result in poor outcomes in surgical patients when
administered prematurely or unnecessarily and is a significant financial burden to health
systems.1
The Joint Commission and the American Medical Association have identified red blood
cell transfusion as 1 of the top 5 overused medical procedures.2 Studies have also determined that
the decision to administer blood during elective surgeries significantly varies between different
institutions and individual practitioners, suggesting that the decision to administer blood is often
not based on evidence but rather on individual behavior.3 Additionally, meta-analyses5 have
concluded that an estimated 40-60% of transfusions administered did not improve health
outcomes, that only 12% of transfusions administered were appropriately used for patients who
needed them, and are thus largely inappropriate. Unnecessary transfusions only increase the risk
for harm and cost while providing minimal benefit. There is a clear need for a paradigm shift in
the utilization of blood products during the perioperative period.

Background
In the United States, blood transfusions are the most common medical procedure
performed in hospitals.6 When used appropriately, allogeneic blood transfusions are crucial life-
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saving interventions essential in perioperative management. The World Health Organization
(WHO) has provisioned that all member states have adequate supplies of safe blood products
accessible to all who require blood transfusions.7 The use of blood transfusions should be based
on safety, efficacy, and quality of treatment in perioperative management. However, an
expansive volume of evidence has emerged correlating blood transfusions to adverse patient
outcomes, increases in morbidity, and mortality in surgical patients.1,4,8–10 Noting this, current
transfusion practices require further evaluation.
Patients may also object to blood transfusions for either personal, safety, or religious
reasons. Healthcare providers must understand and respect these views. One vulnerable
population of particular concern includes Jehovah's Witnesses, whose religious beliefs prohibit
them from receiving blood transfusions, presenting legal, ethical, and perioperative management
dilemmas for anesthesia providers.11 Preoperative, intraoperative, and postoperative optimization
of a patient's own blood can preempt, reduce, or even forgo the need for the use of blood
products.9 Furthermore, noting that blood transfusions lead to adverse outcomes in patients, they
should be avoided with the exceptions of traumas and acute hemorrhage, with emphasis placed
on optimizing a patient's own blood.12 Anesthesia providers must be current on these modalities
to mitigate the over and inappropriate use of blood transfusion.
The concept of Patient Blood Management (PBM) was created in 2008 as a pragmatic
multidisciplinary bundle to reduce the utilization of allogeneic blood transfusions and thus the
associated negative sequelae and costs.13 PBM aims to improve patient outcomes by minimizing
unnecessary allogeneic blood transfusions via optimization of the patient's own blood and
modifiable risk factors. PBM emphasizes 3 pillars which include: (1) optimization of
endogenous erythrocytes; (2) mitigation and reduction of blood loss and bleeding; and (3)
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optimization of a patient's physiological reserves to anemia.14 Each of these pillars is then
applied to the preoperative, intraoperative, and postoperative periods and has proven to reduce
the use of allogenic blood transfusions, thus reducing the sequential associated adverse and
negative sequelae and costs.9
Scope of the Problem
An estimated 30 to 40% of patients before major surgery are anemic, which is the
primary indicator for allogeneic blood transfusions.9 In the United States, 30 million units of
blood are transfused each year, and every 2 seconds, someone is in need of blood products.4,15
Blood is a finite resource; it cannot be manufactured, has a limited period of viability, and
undergoes rigorous quality assurances requiring extensive resources, personnel, and monetary
support to ensure its safety when being administered to patients. In 2020 and 2021, the American
Red Cross declared a severe nationwide blood shortage attributed to a rise in organ transplants,
elective surgeries, and traumas.16 Shortages have forced some hospitals to delay elective
surgeries until supply rebounds.16 Future inadequacy of the national blood supply must also be
accounted for. Shifting demographic trends of the U.S. population have caused a shrinking donor
base of approximately 20% from 2008 to 2019.17 A total of 50% of allogeneic blood transfusions
are administered to those 65 years of age and older, and by 2031 this segment of the population
will double in size.18,19 There is the potential that if the donor base continues to decline and
current utilization practices are maintained, demand will chronically exceed supply in the years
to come.20
A significant portion of blood transfusions continue to be administered inappropriately. It
is estimated that only 12% of transfusions administered to surgical patients result in improved
outcomes and that 59% of blood transfusions provided no benefit to surgical patients, thus
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exposing patients to unnecessary risk and harm.5 Analysis of data from 3000 surgical patients
who received blood transfusions demonstrated that 31% of allogenic blood transfusions did not
have hemoglobin levels drawn prior to the administration of a transfusion.1 Overuse,
inappropriate use, cost, and limited blood supply are chronic themes in transfusion medicine.
New data on questionable efficacy further emphasize the need for improved guidelines and
management of the appropriate use of allogenic blood transfusions.
Consequences of the Problem
Recent studies have continued to emphasize the strong association between transfusions
and adverse patient outcomes. Transfusions are a major multiplier of morbidity and mortality in
surgical patients when compared to non-transfused patients.12 These morbidities include the risk
of transfusion-related infection, transfusion-related acute lung injury (TRALI), transfusionrelated circulatory overload (TACO), anaphylactic reaction, intensive care unit admission,
thromboembolic events, and hemolytic transfusion reactions.13,21 For example, the occurrence of
postoperative infections was anywhere from 2 to 4 times greater for patients who received an
allogeneic blood transfusion.12,22,23 Studies also suggest that the adverse effects of blood
transfusion are dose-dependent.8 The reduction of the use of blood transfusions has also been
associated with decreased length of hospital stay in several tertiary care hospitals.24 Emerging
evidence also suggests that blood transfusions are significantly associated with increased cancer
recurrence and promotes cancer progression.25,26
The economic costs of blood transfusion are immense. Per 1 unit of blood, the cost
ranges from $1200 to $3800 and is expected to increase.27 Most patients will receive more than a
single unit of blood. When considering all factors, blood transfusions are estimated to cost $10
billion annually to the United States healthcare system.28 When implemented, PBM yields
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significant positive results both for patient outcomes and reduction of costs.9 At the University of
California San Diego health system, a study demonstrated a 47% reduction in transfusion for low
hemoglobin levels and a 67% reduction of multi-unit transfusions, saving over $1 million.21
Swiss and Australian studies24,29 demonstrated savings of $3 and $6 million, respectively, with
authors noting that this is likely an underestimation by not accounting for indirect costs and
treatment of any potential complications associated with allogeneic blood transfusions.
Knowledge Gaps
Blood Management was first mentioned in 2008.13 High-quality evidence on PBM and
restrictive transfusion protocols have primarily been published in the last 5 to 10 years.2 Patient
blood management significantly decreases the use of allogeneic blood transfusions and
associated risks.9 Governing medical associations have highlighted the importance of PBM
implementation, especially when noting continued blood shortages associated with COVID19.30,31 The novelty of this multidisciplinary bundle and the state of the current national blood
supply denotes the importance of, and likely knowledge deficit of, PBM among healthcare
providers.
A common barrier cited to implementing PBM protocols is a lack of knowledge and
information among providers.32 A survey among 4952 clinicians was conducted throughout
Europe, and results demonstrated insufficient knowledge of PBM.33 The survey noted that more
than 50% of clinicians do not treat preoperative anemia and 29% stated they did not have
sufficient knowledge on how to treat it.33 Of those who chose to treat the anemia, 38% chose to
treat with a preoperative blood transfusion.33 This highlights the need for additional intervention
among clinicians to increase knowledge on PBM and its perioperative management modalities.
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Increasing attention has been brought to PBM; however, literature assessing awareness among
providers is limited, and the available literature focuses on providers in Europe.
Proposal Solution
During elective surgeries, the decision to initiate allogenic blood transfusions varies
widely between institutions and among individual providers.1 Despite mounting evidence
concerning the overuse of blood transfusion, they continue to be the most common medical
procedure among inpatients in the United States.6 There is a clear need for improved guidelines
regarding the use of blood transfusions, and PBM is an effective evidence-based,
multidisciplinary approach that addresses these concerns.9
Educational modules have been effective in enhancing knowledge among healthcare
providers on various topics.34,35 Utilization of an educational module on PBM will improve
knowledge and change behavior among anesthesia providers to optimize endogenous
erythrocytes better, mitigate blood loss and bleeding, and treat anemia during the perioperative
period. Together, this project will reduce the adverse outcomes and costs associated with
allogenic blood transfusions among all surgical patients.
Summary of Literature
Blood transfusions are overprescribed in the perioperative stage.1–5 The use of blood
transfusions is one of the most important medical developments in the 20th century; however, its
utilization is one of the most ubiquitous medical interventions in modern medical practice as a
way to maintain a patient's optimal cardiopulmonary status. During the perioperative period,
there are protocols and guidelines for the administration of blood product which are not clear,
often resulting in the overuse of blood transfusions due to an abundance of caution from
healthcare providers.1 In direct opposition to historical practices, blood transfusions are not

11
always necessary and may, in fact, cause patients harm resulting in worse outcomes, and are a
significant financial burden to health systems.1
The Joint Commission and the American Medical Association have identified red blood
cell transfusion as the single most common medical procedure.2 Individual behavior, rather than
evidence-based data, is the greatest factor in determining the initiation of blood administration,
and these practices varying across different providers and institutions.3 The majority of blood
transfusions given in the United States are used inappropriately and only a small percentage
(12%) were administered were appropriately used for patients who needed them.5 Most
transfusions in the US increase cost and risk without any clear benefit, current practices are not
sustainable and are in need of change, based on high quality research and evidence. PBM
intentions are to improve safety, efficacy, and quality of treatment through all phases of care for
the surgical patient to mitigate the associated morbidity, mortality, and adverse patient outcomes
prevalent in the perioperative period. Some patients may also object to the use to blood products
for other reasons such as religious, or personal views. Healthcare providers should be able to
accommodate these needs.
Rationale
Patient Blood Management (PBM) is a relatively novel tool conceived in the last 14
years, it strives for a pragmatic multidisciplinary approach to reduce the utilization of blood
transfusions and thus the associated negative consequences.13 At its core, PBM focuses on the
individual’s modifiable risk factors and how to best optimize patients in order to minimize or
overall forgo the use of allogeneic blood transfusions. The three pillars of PBM include: (1)
optimization of hematopoiesis, (2) minimizing surgical blood loss and bleeding, and (3)
optimizing of a patient's physiological tolerance to anemia.14 These principles each have an
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application throughout each phase in the perioperative period and have been proven and tested in
various settings to reduce the use of unnecessary blood transfusions.
Due to PBMs relative novelty, most high quality literature has only been published in
recent years.2 Thus resulting in a knowledge deficit across many providers on the matter and
denoting the importance of educational interventions to increase awareness. Many governing
bodies, such as the World Health Organization and the America Society of Anesthesiologists,
have also noted depleting reserves in blood banks due to the COVID-19 pandemic, which further
emphasizes the importance of conservative blood transfusion usuage.30,31
There has been increasing attention brought towards PBM as a viable tool to address
concerns of safety, and appropriate of a finite resource. However, many providers are still not
proficient in the basic principles of PBM as denoted by a survey on PBM sent to 7 hospitals in
Europe where there were widespread inconsistencies on how to appropriately intervene when
patients were preoperatively anemic.33
Objective
This literature review aims to summarize the impact Patient Blood Management (PBM)
has in the perioperative period through 3 dimensions. First, this review will analyze the latest
evidence-based interventions in Patient Blood Management and its rationale. Next, it will assess
the validity of utilizing the PBM initiative in reducing the utilization of allogeneic blood
transfusions in the perioperative period and associated adverse patient outcomes. Finally, the
literature will examine past implementation of PBM and review what financial impact PBM has
when implemented in facilities.
Methodology
Eligibility Criteria & Information Sources
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Peer-reviewed articles selected for the literature review were chosen based on specific
inclusion and exclusion criteria. Search limits included articles studying adult populations,
published from 2015 and forward, and were available in English. Exclusion criteria included
studies where subjects were less than 18 years of age. Database sources used for the literature
review were accessed through Florida International University (FIU) library services. A review
of the current literature for this topic was conducted via queries of the electronic databases
PubMed and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). The
literature review was guided by utilizing the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA). Keyword search terms were identified based on the clinical
question, using Boolean operators and search symbols. These included: Patient Blood
Management, Bloodless Surgery, Perioperative, restrictive transfusion strategy, and anesthesia
provider.
Search Strategy
Key search terms were further expanded with the assistance of the FIU Health Science
Librarian and included ("Patient Blood Management") AND ("Perioperative"). This search
yielded a total of 100 articles through the CINAHL database and 145 articles from MEDLINE.
This search was further refined to include only adults ages 18 and over, published in the last 6
years, in English, and available in full text. This yielded 55 and 53 articles, respectively. Titles
were excluded if the focus was not on the PBM protocol. The search was further refined to
articles that focused on specific providers: (Anesthesia* OR Anesthesiologist* OR Anesthetist*).
A total of 23 articles were then selected for a full review of the abstract; of those articles, 11
were assessed by reading the full text. Articles were then excluded if management focused on
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intensive care and/or pediatric patients. Only the articles that met the highest level of research
were chosen, leaving 8 articles for review.

Table 1: Search Key Words
First
Keyword

Second
Keyword

Third Keyword

“Patient
“Perioperative “Anesthesia” OR
Blood
“Anesthetist” OR
Management”
“Anesthesiologist”
Results
Study Characteristics
The 8 articles selected for the literature review comprehensively analyze the fundamental
conceptual framework and concerns related to Patient Blood Management. Overall, these articles
assess current transfusion practices, advantages and disadvantages of PBM, implementation and
patient outcomes, financial consequences, and current knowledge on PBM. Several articles
located on the topic definitively demonstrate that reducing the overutilization of allogeneic blood
transfusions in the perioperative period can reduce the associated adverse outcomes and cost.
Ferraris et al8 analyzed current transfusion practices, the type of patients who receive
allogeneic blood transfusion during surgery, and how it affects patient outcomes. The authors,
who initially conceptualized PBM over 10 years, further analyzed the effectiveness of PBM and
its future potential, while other studies further support the use of PBM to reduce unnecessary
transfusions.2,9 Post-implementation PBM also has a significant financial impact on health
systems.36 To effectively support the potential need for transfusion practice changes, Manzini et
al33 evaluated knowledge and current practices among clinicians, the first such study assessing
knowledge of PBM that has been conducted in the United States. Finally, a meta-analysis was
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conducted on Patient Blood Management and its effectiveness in reducing negative
consequences and costs of blood transfusions.37
All the studies were centered on adults 18 years of age and older. A total of 4 of the
studies were systematic reviews or meta-analyses with a Level I evidence level.2,10, 36,37 An
additional 3 were cohort studies associating patients who received blood transfusions with a
variety of outcomes.8,25,33 Another study was a Clinical Focused Review by the original author
who first conceptualized Patient Blood Management.9
Results of Individual Studies
(1) Ferraris et al8 sought to determine if there are an identifiable set of patient
characteristics that can be correlated with adverse and positive patient outcomes when given an
allogeneic blood transfusion. This study was conducted via queries of the American College of
Surgeons National Surgical Quality Improvement Project database of patients who received
allogeneic blood transfusions within 72 hours of their operative procedure and compared those
who did not receive blood, noting differences in morbidity and mortality. Through the queries,
470 407 patients were included, with data retrieved from surgeries between 2010 and 2012. The
queries did exclude trauma patients, pediatric patients, patients on cardiopulmonary bypass and
aortic procedures. Surgeries that were included that comprised the vast majority of blood
transfusions including cardiothoracic surgery, general surgery, neurosurgery, and vascular
surgery.8
Patients who received 1 or more units of red blood cells within 72 hours of surgery had a
respective mortality or severe morbidity rate of 11.3% and 55.4%.8 Compared to non-transfused
patients, associated mortality and morbidity was 1.3% and 6.1%, respectively. There was a 300400% increase in morbidity and mortality for anemic patients who received a blood transfusion
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compared to non-transfused anemic patients. Patients considered low risk for adverse surgical
outcomes had the highest mortality and morbidity rates of transfused patients. High-risk patients
do not have significantly increased risk when receiving blood transfusions. This study highlights
the importance of effective preoperative assessment of transfusion risk profiles. The authors
further support the concept of limiting transfusions used to minimize operative risk in their
discussion. This study also noted that blood transfusion practices vary widely across institutions,
and, further, guidelines are needed to optimize patient outcomes.8
(2) One meta-analysis, by Trentino et al10 , assessed the effects of restrictive and liberal
transfusion strategies on patient mortality. The authors support the utilization of restrictive
transfusion thresholds for most patient populations.10 Databases used were MEDLINE, Embase,
Web of Science Core Collection, PubMed, Google Scholar, and the Joanna Briggs Institute EBP
Database. Only systematic reviews and meta-analyses were included. A total of 346 articles were
screened, while 43 full-text articles were assessed for eligibility. A final 19 studies were included
in the qualitative synthesis. Of the meta-analyses reviewed, 12 (75%), found there was no
reported difference in mortality between liberal and restrictive transfusion practices. Another 4
meta-analyses (25%) supported significantly lower mortality for patients where restrictive
transfusion practices were utilized. Overall, the authors supported the use of restrictive
hemoglobin thresholds in most patient populations.10
(3) Spahn et al9, the original authors who first conceptualized PBM over the course of 10
years, sought to affirm and narrate its clinical application, limitations, and potential for future
uses throughout the perioperative period.9 The article summarizes and synthesizes PBM
utilization in the preoperative, intraoperative, and postoperative periods, specifying what
interventions and lab values should be used to optimize patients, and provides a clinical
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framework for PBM implementation. The authors note a variety of PBM interventions.9
Preoperatively, the authors suggests the use of intravenous iron and erythropoietin.
Intraoperatively, measures such as reducing transfusion thresholds, novel surgical techniques,
cell savage, and normovolemic hemodilution are recommended. Postoperatively, PBM endorses
the use of restrictive transfusion thresholds, minimization of laboratory blood draws, and goaldirected coagulation algorithms. Overall, the review affirms that blood transfusions are
associated with prolonged hospitalization, intensive care admission, infection, thromboembolic
events, and mortality.9
(4) A systematic review by Sadana et al2 reviewed 31 studies by comparing restrictive
and liberal transfusion strategies. This article promotes the utilization and development of Patient
Blood Management programs, providing specific methods for optimal transfusion practices. All
studies reviewed were randomized control trials (RCTs) published in the last 10 years at the time
of publication. Included were 7 of the 8 most cited trials, 4 of which were published in the
previous 4 years at the time of publication. The total sample size was 12 587.2 The authors
established cutoffs for transfusions; stating that red blood cell transfusions are not indicated in
hemodynamically stable patients with 7g/dl or greater hemoglobin levels. Further, transfusions
are not indicated in orthopedic or cardiac surgery for patients with underlying cardiovascular
disease with hemoglobin levels of 8g/dl or greater. The article also provided a blueprint for
specific methods for optimizing transfusion practice that would lead to an increased quality of
care and reduced costs.2 These methods included nutritional optimization, pre-operative anemia
treatment, and novel cell savage techniques.2
(5) With high-quality evidence emerging on the topic of PBM, Althoff et al37 conducted a
systematic review and meta-analysis. This study aimed to determine the effectiveness of PBM
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implementation in reducing morbidity, mortality, and improving clinical outcomes in patients
throughout the perioperative period. All studies included must have addressed each of the 3
pillars of PBM. Overall, 17 studies were analyzed, yielding a sample size of 235 779. Of those,
100 886 were participants pre-PBM implementation, and 134 893 were post-PBM
implementation. The authors conclude by supporting the use of PBM in various healthcare
settings. The meta-analysis revealed implementation of PBM significantly reduces the incidence
of transfusion by 39%, decreases the number of red blood cells (RBC) units transfused per
patient, reduces the length of hospital stay, reduces the number of total complications, and
decreases mortality rate.37
(6) A subsequent study by Meybohm et al36 used the data from Althoff et al37 to conduct
a thorough cost-benefit analysis of the financial benefit of implementing comprehensive Patient
Blood Management programs through the previous meta-analysis. Sampling methods and
interventions were the same as the aforementioned study. The cost of utilization of PBM
interventions, such as cell salvage, tranexamic acid, and iron supplementation was $143.42 per
patient. Patients under PBM had lower transfusion rates, decreased length of stay, and fewer
units transfused in total. This yielded a savings of $174.05 per patient.36 Overall, comprehensive
implementation of PBM improves patient safety and is cost-effective.36
(7) There are many patient populations where emerging evidence continues to highlight
the detrimental outcomes that may be associated with red blood cell transfusions; one population
of particular concern are cancer patients. Wu et al25 conducted a retrospective cohort study of
colorectal cancer patients (n=4030) post-red blood cell transfusions to assess the recurrence of
cancer and overall mortality. Records were reviewed with a median follow-up time of 46.1
months. Propensity score matching was used to mitigate difference in patient characteristics and
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Cox regression analysis was utilized. Analysis demonstrated that red blood cell transfusions were
associated with shorter disease-free status and lower overall mortality. Larger transfusion
amounts were associated with even higher rates of overall mortality. The authors note that
overall evidence oftentimes remains inconclusive, and the study supports measures aimed at
minimizing and restricting transfusion thresholds.25
Patient Blood Management was first mentioned in 2008.13 High-quality evidence on
PBM, and restrictive transfusion protocols have primarily been published in the last 5 to 10
years.2 The novelty of this multidisciplinary approach led Manzini et al33 to conduct a multi-site
cohort study assessing clinician knowledge on PBM principles and practices in 7 hospitals via a
multi-site survey. A 39-item survey on PBM was created and sent to 7 hospitals in Europe. A
Yates correct chi-squared test was used for analysis. The survey was sent to 4953 clinicians
resulting in 788 (16%) responses. Participants included surgeons, anesthesia providers, and
medical specialists. Notable results were that 24% of respondents did not associate preoperative
anemia with perioperative morbidity and mortality. Half of the clinicians did not treat
preoperative anemia, and of those who did treat, 38% chose to treat with red blood cell
transfusion. Responses indicated poor knowledge of PBM based on the inconsistencies in the
treatment of preoperative anemia.33 This highlights the need to enhance understanding of PBM
among healthcare providers.
Discussion
Summary of the Evidence
Recent studies have continued to emphasize the strong association between transfusions
and adverse patient outcomes. Transfusions are a significant multiplier of morbidity and
mortality in surgical patients when compared to non-transfused patients.8 These morbidities
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include the risk of transfusion-related infection, transfusion-related acute lung injury (TRALI),
transfusion-related circulatory overload (TACO), anaphylactic reaction, intensive care unit
admission, thromboembolic events, and hemolytic transfusion reactions.9 Studies also suggest
that the adverse effects of blood transfusion are dose dependent and that the reduction of the use
of blood transfusions has also been associated with decreased length of hospitalization.8 37
Additionally, emerging evidence also suggests that blood transfusions are significantly
associated with increased cancer recurrence and promotes cancer progression.25,26 The economic
cost of blood transfusions is immense, and meta-analyses have revealed that PBM is a significant
cost-saving measure if effectively implemented.36
Further intervention to enhance knowledge is needed and warranted for this significant
patient quality concern and financial burden to health systems. To address these concerns, the
literature supports the use of Patient Blood Management principles in the perioperative phase of
surgical care. High-quality evidence supports the utilization of PBM in health systems to
mitigate the associated detrimental risks and financial impact.
Some of these modalities include intravenous iron and erythropoietin, novel surgical
techniques, cell savage, normovolemic hemodilution, restrictive transfusion thresholds,
minimization of laboratory blood draws, and goal-directed coagulation algorithms.2,9 The novelty
of this multidisciplinary bundle denotes a likely knowledge deficit of PBM among healthcare
providers. Of clinicians surveyed in one study, over half did not treat preoperative anemia. Of
those who did treat, a significant portion (38%) treated with a blood transfusion, directly against
the pillars of PBM.33 A potential barrier to implementing PBM protocols is a lack of knowledge
and information among providers; further intervention to enhance knowledge may be warranted.
Conclusion
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Patient blood management is a practical, evidence-based, multidisciplinary approach that
addresses the adverse sequelae and costs associated with inappropriate blood transfusion
administration. Despite mounting evidence concerning the overuse of blood transfusions, they
continue to be the most common medical procedure among inpatients in the United States. The
literature reviewed assessed the main concerns surrounding the overuse of allogeneic blood
transfusions and evidence supporting PBM implementation. Overall, it can be argued that blood
transfusions prolong hospitalization, as well as lead to an increase in intensive care admissions,
infections, thromboembolic events, morbidity and mortality, and are a significant patient quality
concern and financial burden to health systems.
To address these concerns, the literature supports the use of PBM principles in the
perioperative phase of surgical care. There continues to be a significant knowledge deficit
regarding PBM among clinicians due to the novelty of the initiative. High-quality evidence
supports the utilization of PBM in health systems to mitigate the associated detrimental risks and
financial impact. The information obtained from this literature review lays the framework for a
quality improvement (QI) project focusing on enhancing provider knowledge on the principles
and practices of PBM.
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Table 1: Summary of Literature Review
Author(s)

Purpose

Althoff et al
(2019)37

The purpose
of this study
was to
determine the
effectiveness
of PBM
implementatio
n in reducing
morbidity,
mortality and
improving
clinical
outcomes in
patients
throughout the
perioperative
period.
This study
sought to
determine if
there are an
identifiable set
of patient
characteristics
that are
correlated
with adverse
patient
outcomes and
positive

Ferraris et
al (2015)8

Methodology/
Research
Design
Systematic
Review and
Meta-analysis
Level I

Intervention(s)/
Measures
A search was done
using the Cochrane
Library and Medline
Databases. Dates of
publications ranged
from 2000 to 2017.
All studies included
must address each of
the three pillars of
PBM.

Sampling/Setting

Primary Results

17 studies were
included with a
large sample size of
participants.
(n= 235, 779).

Implementation of PBM
significantly reduces the
incidence of transfusion by
39%.

Pre-PBM
implementation.
(n = 100, 886)
Post-PBM
implementation.
(n = 134, 893)

Retrospective
Observational
Cohort Study
Level III

Queried the American
College of Surgeons
National Surgical
Quality Improvement
Project database of
patients who received
blood within 72 hours
of their operative
procedure compared to
those who did not
receive blood, noting
differences in

Sample size was
large (n= 470,407).

Relevant Conclusions

The study further
supports PBM
implementation in all
healthcare settings.

Decreased the number of
RBC units transfused per
patient, decreased length of
hospital stay, decreased
number of total
complications, and
decreased mortality rates.

Of patients who received >
1 allogeneic blood
transfusion within 72 hours
Data were pooled
of surgery had a respective
from patients
mortality or serious
between 2010 to
morbidity of 11.3% and
2012. The database 55.4%. Compared to nonexcluded trauma
transfused patients,
and pediatric
associated mortality and
patients, the authors morbidity was, 1.3% and
further excluded
6.1%, respectively.
patients on
cardiopulmonary

Improved preoperative
assessment of
transfusion risk profiles
is needed for patients.
The authors support the
concept of limiting
transfusions used to
minimize operative
risk. Blood transfusion
practices widely vary
across institutions, and
further guidelines are
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patient
outcomes
when given an
allogeneic
blood
transfusion.

Manzini et
al (2018)33

This study
assesses
clinicians'
knowledge of
PBM
principles and
practices in 7
hospitals via a
multi-site
survey.

Meybohm et The study
al (2020)36
sought to
conduct a

morbidity and
mortality.

bypass and aortic
procedures.
Surgeries included
were cardiothoracic
surgery, general
surgery,
neurosurgery, and
vascular surgery.
30-day morbidity,
mortality, and
postoperative
complications were
measured.

Multi-Site
Cohort Study
Level IV

Metanalysis
Level I

There was a 300- 400%
increase in morbidity and
mortality for anemic
patients who received a
blood transfusion
compared to nontransfused anemic patients.
Patient considered to be
low risk for adverse
surgical outcomes has the
highest mortality and
morbidity rates of
transfused patients. Highrisk patients do not have
significant risk when
receiving blood
transfusions.

needed to optimize
patient outcomes.

Responses indicated
poor knowledge of
PBM. There were
inconsistencies on the
treatment of
preoperative anemia.
Programs are needed to
enhance knowledge on
Patient Blood
Management.

A 39-item survey on
PBM was created and
sent to 7 hospitals in
Europe. Yates correct
chi-squared test was
used for analysis.

Participants
included surgeons,
anesthesia
providers, and
medical specialists.
The survey was
sent to 4,953
clinicians resulting
in 788 (16%)
responses.

24% of respondents did not
associate preoperative
anemia with perioperative
morbidity and mortality.

All studies included
must address each of

17 studies were
included with a

The cost of utilization of
Comprehensive
cell salvage, TXA, and iron implementation of
PBM improves patient

Half of the clinicians did
not treat preoperative
anemia. And those who did
treat, 38% chose to treat
with red blood cell
transfusion.
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Sadana et al
(2018) 2

thorough costbenefit
analysis of the
financial
benefit of
implementatio
n of
comprehensiv
e PBM
programs
through metaanalysis
This study
reviewed the
latest
transfusion
practice
guidelines and
evidence
supporting
these
guidelines.
The goal of
this
publication is
to promote the
utilization and
development
of PBM
programs and
provided
specific
methods for

the three pillars of
PBM.
Endpoints measures
include: transfusion
rate, transfused units
per patient, LOS, the
total number of
complications, and
mortality.

Systematic
Review
Level I

31 studies were
reviewed which
compared restrictive
versus liberal
transfusion strategies.

large sample size of
participants.
(n= 235, 779)
Pre-PBM
implementation.
(n = 100, 886)
Post-PBM
implementation.
(n = 134, 893)
All studies were
RCTs and
published in the last
10 years at the time
of publication.
Seven of the eight
most cited trials
were included, four
of which were
published in the last
four years at the
time of publication.
(n=12, 587)

supplementation was
€124.04 per patient.

safety and is costeffective.

Patients under PBM have
lower transfusion rates,
decreased LOS, and less
units transfused in total.
This yielded a saving of
€150.64 per patient.
Overall cost savings was
€21.60 per patient.
Red Blood cell transfusion
is not indicated in
hemodynamically stable
patients with hemoglobin
levels of 7 g/dl or greater.
Transfusions are not
indicated in orthopedic or
cardiac surgery for patients
with underlying
cardiovascular disease with
hemoglobin levels of 8 g/dl
or greater.

The study supports the
implementation of
Patient Blood
Management programs.
The authors provide a
blueprint for specific
methods for optimizing
transfusion practice
which will lead to
increase quality of care
and reduced costs.
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Spahn et al
(2020)9

Trentino et
al (2020)10

optimal
transfusion
practices.
The authors
sought to
affirm the use
of PBM and
summarize its
clinical
application
throughout the
perioperative
periods, its
limitations,
and potential
for future use.

This study
aimed to
synthesize the
outcomes of

Clinical Focused
Review:
Literature
Review
Level V

Systematic
Review and
Meta-analysis

The articles
summarize and
synthesized the
utilization of PBM in
the preoperative,
intraoperative, and
postoperative periods
and specified what
interventions
biometrics should be
used to optimize
patients, and provided
a clinical framework
for PBM.

The authors narrate
the biometric
values, tools, and
interventions
supported in PBM
and detail the
evidence to support
their endorsement.

Blood transfusions are
associated with prolonged
hospitalization, intensive
care admission, infection,
thromboembolic events,
and mortality.

The search utilized
publications from
2008 to 2018.
Databases used were

A total of 346
articles were
screened. And 43
full-text articles

12 meta-analyses (75%)
reported no difference in
mortality between liberal

Patient blood
Management reduced
the utilization of
allogeneic erythrocytes
transfusions, associated
negative sequelae, and
costs.

Preoperatively the
literature suggests the use
of IV iron and
erythropoietin.
Intraoperatively, measures
such as reducing
transfusion thresholds,
novel surgical techniques,
cell savage, and
normovolemic
hemodilution.
Postoperatively, PBM
endorses the use of
restrictive transfusion
thresholds, minimization of
laboratory blood drawn,
and goal-directed
coagulation algorithms.
The authors support the
utilization of restrictive
transfusion thresholds
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Wu et al
(2018)25

restrictive and
liberal
transfusion
strategies on
patient
mortality by
reviewing
systematic
review and
meta-analyses.
This study
retrospectively
assessed the
recurrence of
and mortality
among
colorectal
cancer patients
who have red
blood cell
transfusion.

Level I

Retrospective
Cohort Study
Level IV

MEDLINE, Embase,
Web of Science Core
Collection, PubMed,
Google Scholar, and
the Joanna Briggs
Institute EBP
Database. Only
systematic reviews
and meta-analyses
were included.
Patients records were
evaluated for cancer
outcomes focusing on
postoperative overall
survival and disease
free status.

were assessed for
eligibility.

and restrictive transfusion
practices.

A final 19 studies
were included in
the qualitative
synthesis.

4 meta-analyses (25%)
supported significantly
lower mortality for patients
where restrictive
transfusion practices were
utilized.

4,030 were
reviewed with a
median follow-up
time of 46.1
months. Propensity
score matching was
used to mitigate
difference in patient
characteristics and
cox regression
analysis was
utilized.

Analysis demonstrated that
red blood cell transfusions
were associated with
shorter disease-free status
and lower overall
mortality. Larger
transfusion amounts with
associated with even higher
rates of overall mortality.

can be applied to most
patient populations.

The authors support
strategies aiming at
minimizing transfusion
requirements.
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Purpose/PICO Clinical Questions/Objectives
As a central aspect of improving the use of PBM in practice, results from the literature
must be translated into a workable formula, in this case the purpose, PICO (population,
intervention, comparison, outcome) clinical question, and objectives for the project must be
spelled out. The purpose of this quality improvement project is to increase anesthesia provider
knowledge of PBM. The PICO question to guide this project is therefore: In anesthesia providers
(P), does the use of an educational module on Patient Blood Management (I), increase
knowledge of perioperative PBM (O) when compared to before the educational intervention (C)?
Breaking down this question into its respective elements, the following can be seen:
•

Population (P): Anesthesia Providers

•

Intervention (I): Patient Blood Management educational module.

•

Comparison (C): Pre-education knowledge level

•

Outcomes (O): Improved provider knowledge of perioperative Patient Blood
Management

Goals and Outcomes
The goal of this DNP project is to increase anesthesia provider knowledge on Patient
Blood Management as a part of the standard of care. In the clinical site proposed for this project,
there is currently no Patient Blood Management protocol. This project will be an important step
in closing the knowledge gap on PBM and eventual improved competence in the proper
utilization of allogeneic blood transfusions. The goals and objectives of this DNP project were
guided by the Specific, Measurable, Attainable/Achievable, Relevant, and Timely (SMART)
tool.38
Specific
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Anesthesia Providers (Certified Registered Nurse Anesthetists and Physician
Anesthesiologist) will be provided with an educational module on Patient Blood Management.
Utilization of an educational module on PBM will improve knowledge and change behavior
among anesthesia providers to optimize endogenous erythrocytes better, mitigate blood loss and
bleeding, and treat anemia during the perioperative period.
Measurable
The effectiveness of the educational module on Patient Blood Management will be
calculated through the analysis of a pre- and post-educational module questionnaire that will be
provided to participants before and after the educational intervention. Outcomes will be
measured by evaluation of the anesthesia provider’s knowledge on PBM, the appropriate use of
allogeneic blood transfusions, and awareness of the negative sequalae associated with blood
transfusions utilization. Item analysis of the pre and post intervention questionnaire will be
utilized for metrics.
Achievable
As a result of the provider education module, the development of which is guided by best
andragogical techniques and evidence-based practice, anesthesia providers will have improved
knowledge and awareness on PBM, proper utilization of blood transfusions, and be able to
promote more restrictive transfusion practices. Attendance and demonstration of knowledge
gained demonstrate the achieveable nature of this goal.
Realistic
Utilization of an educational module on PBM will improve knowledge levels and change
behavior among anesthesia providers to optimize endogenous erythrocytes better, mitigate blood
loss and bleeding, and treat anemia during the perioperative period.
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Timely
The Patient Blood Management Educational module intervention will be created and
implemented over the course of 6 months. Within 3 months afterwards, item analysis will occur
of the pre and post questionnaire.
Program Structure
The development and implementation of the educational module on Patient Blood
Management will require a collaborative effort. A comprehensive analysis will be conducted to
accurately assess the needs and opportunities at the clinical site in order to guide the value,
significance, and dissemination of the intervention.38 A strength, weakness, opportunities, and
threats (SWOT) analysis will be conducted to evaluate the internal and external characteristics
and threats to the project’s development.
SWOT Analysis
Strengths
Mount Sinai Medical Center in Miami Beach is Florida’s largest private, independent,
non-profit, teaching hospital.39 It was ranked in the top 5% of hospitals in the United States for
the year 2020/2021 and is the only Ivy League-affiliated hospital in South Florida.39 Being a
teaching hospital, Mount Sinai regularly integrates the latest evidence-based practice and
encourages scholarly efforts, making it more readily adaptable and accepting to change. Miami
Beach Anesthesiology Associates, Inc has coordinated all anesthesia services for Mount Sinai
Medical Center since its inception in 1997.
Throughout its history, the group has trained hundreds of Student Registered Nurse
Anesthetists and supported many through their doctoral theses, highlighting its unique ability to
seamlessly integrate and support scholarly research. Currently, there are 30 Certified Registered
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Nurse Anesthetists and 20 Physician Anesthesiologist employed at Mount Sinai Medical Center.
This project has the support of key stakeholders at Mount Sinai. Carmen Chan DNP, CRNA,
APRN will serve as the main clinical site advisor; she has been employed at the group since
2019. The Chief Nurse Anesthetist is Jampierre Mato DNP, CNRA, APRN, who serves as
Executive CRNA Director of Miami Beach Anesthesiology Associates, has been in this position
for over 13 years, and has trained over 500 student registered nurse anesthetists. He has several
scholarly works published, has expressed support for this project and will facilitate in this
project’s implementation.
Weaknesses
Mount Sinai Medical Center currently has no PBM or bloodless surgery protocol. With
any proposed change, resistance to said change will occur. There are approximately 50
anesthesia providers at Mount Sinai Medical Center. While the intention is to educate all
anesthesia providers, there are time and logistical constraints that may impede in obtaining a
sample size that will yield significant results.
At Mount Sinai Medical Center there are currently 30 Certified Registered Nurse
Anesthetist, and 20 Physician Anesthesiologist, obtaining an adequate sample size for this
intervention that will yield statistically significant results may be challenging. Lastly, Mount
Sinai Medical Center only accepts a limited amount of Doctoral Nursing Practice projects for
implementation each year, and there is a possibility this project will not be accepted for
implementation and thus other avenues will need to be explored in the event of this occurrence.
PBM is intended as a multidisciplinary bundle and although anesthesia providers are
paramount in the administration and the decision to transfuse red blood cells, surgeons, nurses,
and other healthcare professionals should be involved to establish a comprehensive front in
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addressing the problem. This project aims towards education anesthesia providers only and thus
limiting its scope excludes other vital components of PBM. Additionally, certain PBM
interventions, such as nutritional status optimization, would not be realistic in this clinical setting
as anesthesia providers often do not see patients until the day of surgery. Mount Sinai Medical
Center does not currently house a pre-evaluation of patients by anesthesia services before the day
of surgery.
Opportunities
Mount Sinai Medical Center currently has no protocol on Patient Blood Management or
Bloodless surgery techniques. The site has many of the resources to be able to conduct such
interventional change. Additionally, the educational module has the support of the Chief Nurse
Anesthetist. The novelty of this multidisciplinary bundle denotes a likely knowledge deficit of
PBM among healthcare providers. Of clinicians surveyed in 1 study, over half did not treat
preoperative anemia. Of those who did treat, a significant portion (38%) treated with a blood
transfusion, directly against the pillars of PBM.33 This denotes a further need. Mount Sinai is
also a teaching hospital with staff that are likely to be receptive to such an intervention. To our
knowledge no such intervention on Patient Blood management has been conducted by a previous
doctoral student and there is no protocol in place for bloodless surgery or PBM.
Threats
Threats in a SWOT analysis are defined as any factor that may potentially hinder or
interfere with the intervention’s ability to achieve its desired objectives.38 One of these includes
resistance to change or deviation from the current standard of care. Additionally, Patient Blood
Management is best implemented when presented as a full interdisciplinary bundle, but this
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educational module intervention is intended to target only anesthesia providers and not the other
components of PBM.
Other external factors include a potentially low response rate to the survey which could
yield a small sample size that is not able to produce results of statistical significance. There is
also the potential that many of the anesthesia staff are trained on how to utilize PRBCs
appropriately and education on PBM may not be needed because they follow best practices.
Conversely, some providers may be resistant to changing their practice on what they consider
appropriate utilization of PRBCs.
Definition of Terms
For the purpose of this quality improvement project, the following terms have been
defined:
•

Allogenic blood: Involves 2 individuals of the same species, where the donor and
recipient are 2 separate individuals.

•

Autologous blood: Blood deriving from the same individual, where donor blood and the
recipient is the same person.

•

Bloodless surgery: Specialized surgical service that provides alternative modalities of
treatment for patients for whom blood transfusions are not possible i.e., Jehovah’s
Witnesses.

•

Patient Blood Management: According to the Society for the Advancement of Patient
Blood Management, PBM is defined as “the timely application of evidence-based
medical and surgical concepts designed to maintain hemoglobin concentration, optimize
hemostasis and minimize blood loss in an effort to improve patient outcome.”37
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•

Restrictive Transfusion Practices: Practices that help guide the utilization of blood
transfusions on multiple patient factors rather than the sole “trigger” of low hemoglobin
levels.
Conceptual Underpinning and Theoretical Framework of the Project
The conceptual framework of this project is based on Kotter’s change model, which is a

set of sequential steps designed to establish and sustain organizational change. The 8 steps of this
process are: to create a sense of urgency that the change is needed, form a strong guiding
coalition of leaders, define a clear vision for the change, communicate the vision to obtain buyin, empower action by removing obstacles, generate short-term wins, immediately build on the
short-term successes, and anchor the change in the organizational culture.40 Kotter’s model has
been time-tested over several decades, as well as shown to be effective and is the leading
contemporary model of institutional change.
Kotter’s model focuses on steps that will lead to change, particularly those pertinent to
this educational module, including establishing a sense of urgency, creating a coalition,
developing a vision, and empowering a base of people to take action. These steps can be
introduced through information dissemination in the educational module and should foster a
culture of change in relation to blood administration among anesthesia providers.
Patient blood management is a practical, evidence-based, multidisciplinary approach that
addresses the adverse sequelae and costs associated with inappropriate blood transfusion
administration. There continues to be a significant knowledge deficit regarding PBM among
clinicians, due to the novelty of the initiative. High-quality evidence supports the utilization of
PBM in health systems to mitigate the associated detrimental risks and financial impact. The
information obtained from the 8 studies lay the framework for a quality improvement (QI)
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project focusing on enhancing provider knowledge on the principles and practices of Patient
Blood Management. Following this intervention, additional QI initiatives may be warranted to
continue improvement on PBM in this facility, as ingraining a change in practice takes time and
Kotter’s change model provides a systematic flow to define, implement, and secure that changes
are sustainable.
Methodology
Setting and Participants
This study will take place at Mount Sinai Medical Center with the private anesthesia
group Miami Beach Anesthesiology Associates, LLC. There are a total of 50 anesthesia
providers; 20 are Physician Anesthesiologists, and 30 are Certified Registered Nurse
Anesthetists. The practice is located in Miami Beach, Florida.
Description of Approach and Project Procedures
The DNP project will commence by asking anesthesia providers at Mount Sinai Medical
Center to participate in the study. A pre- and post-test design will be used to measure PBM
knowledge and competency. Data collected before the educational intervention will include
demographic information, provider’s degree, and years in practice.
A team of expert stakeholders will be identified, with the goal of assessing and improving
anesthesia provider’s knowledge on Patient Blood Management. The expert stakeholders will
guide the development of the pre- and post-intervention questionnaire and the development of
the educational module intervention. Participants will be first provided with the pre-intervention
assessment tool to measure their knowledge on appropriate utilization of PBM, such as
optimization of endogenous erythrocytes, mitigation of blood loss and bleeding, and effectively
treating anemia. Next, the participants will be provided with an educational intervention
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addressing the core tenants of Patient Blood Management. The intervention will be conducted
through a PowerPoint presentation through in-services. After the intervention, participants will
then take an additional questionnaire that will assess their post-educational knowledge of the
intervention, with results then analyzed.
Protection of Human Subjects
All providers who participate in the educational module will be invited to do so via email
or in person. Should the Institutional Review Board (IRB) deem that this study poses more than
minimal risk, participants will be further presented with a HIPPA compliant survey platform for
consent. Participants have the right to refuse consent for participation at any point.
Benefits of participation include potential improvement of knowledge and competence
around the topic of Patient Blood Management. All data will be de-identified; however, due to
the sample size of the project it is possible that participants may be recognized through indirect
identifiers. All data will be protected through password-encrypted databases only accessible to
the co-investigator.
Data Collection
Data to be collected will include information such as years providers have been
practicing, education, and if they are familiar with PBM. A 21-item survey will be used to assess
providers current knowledge level of PBM prior to the educational module intervention. Higher
scoring individuals will indicate a higher level of competence in Patient Blood Management.
Items will be scored on with multiple choice and select all that apply questions. After the
intervention, individuals will be asked to take the questionnaire again to assess for changes in
knowledge.
Data Management and Analysis Plan
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Data will be stored in an electronic database to which only the co-investigator will have
access. No direct identifiers will be collected, and results will be reported as aggregate data.
Scores will be compared pre- and post-intervention.
Discussion of the Results with Implications to Advanced Nursing Practice
A hypothesis yielding valid results would have positive implications for the intervention.
It would imply that an educational module on PBM is an effective way to enhance knowledge
with the potential to reduce overutilization of blood transfusions. Educational modules have been
effective in enhancing knowledge among healthcare providers on various topics.34,35 Utilization
of an educational module on PBM will improve knowledge and change behavior among
anesthesia providers to optimize endogenous erythrocytes better, mitigate blood loss and
bleeding, and treat anemia during the perioperative period. This will then reduce the adverse
outcomes and costs associated with allogenic blood transfusions among all surgical patients.
Conversely, a hypothesis yielding negative results could mean that the educational module was
inadequate, or that the anesthesia providers may have already had adequate knowledge on PBM
principles. Following this intervention, next steps can be identified where the greatest need for
improvement may be identified such as outlining a PBM protocol or initiation of a scenariobased assessment tool of when providers would choose to transfuse or not. This will be
dependent on results from the survey.
Timeline
To further increase operationalization of the proposed DNP project, a timeline for the
completion of significant activities that are related to the project is included below, an overview
of the key activities necessary for the completion of this project, along with the time frame in
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which each specific activity will be completed. All project components will be completed over
the next 12 months starting in January 2022 with a target completion date of December 2022.
Project Tasks
1. Develop the education intervention
2. Develop the Patient Blood Management questionnaire
3. Choose an electronic database
4. If needed – write consent
5. Request IRB approval
6. Create and send study invitation
7. Administer pretest questionnaires
8. Perform educational intervention
9. Administer posttest
10. Review and code provider progress notes
11. Analyze data
Project Timeline

Invite providers to
partiicpate via email

Consent
Participants

Administer preintervention
questionnaire

Educational
Intervention

Post Intervention
questionnaire

Review, Code,
and Dissmieatr
results
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RESULTS
Demographics
A total of 10 CRNAs participated in the study. Demographics of the participants were 8
females, and 2 males, with ages ranging from 27 to 63. Of those who participated 7 held a
doctoral degree in anesthesia, 2 masters degrees, and 1 bachelors degree. Ethic makeup included
2 Caucasian, 1 African American, 2 Asians, 4 Hispanics, and 1 who self identified as “other”.
Response rate to both the pre and post intervention questions was 100%.
Table 1. Participant demographic data (N=10)

Gender, n (%)

Characteristics
Male
Female

Participants
2 (20%)
8 (80%)

Age, n (%)

20-29
30-39
40-49
50-59
60+

2 (20%)
2 (20%)
4 (40%)
1 (10%)
1 (10%)

Ethnicity, n (%)

African American
Asian
Caucasian
Hispanic
Other

1 (10%)
2 (20%)
2 (20%)
4 (40%)
1 (10%)

Bachelors
Masters
Doctorate

1 ( 10%)
2 ( 20%)
7 (70%)

Level of Education, n (%)

Pre and Post Test Questionnaire
Item 1 (Figure 1) was a select all that apply question which stated: “Red blood cell
transfusions increase the risk of?” All responses were correct. Pre-intervention, 4 responses
stated they increased the length of hospitalization, 1 respondent correctly identified they increase
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the recurrence of cancer, 4 responses stated increase the risk of post-operative infections, and 6
responses indicated they increase patient mortality overall. In the post-intervention questionnaire,
6 responses stated they increased the length of hospitalization, 7 respondent correctly identified
they increase the recurrence of cancer, 5 responses stated increase the risk of post-operative
infections, and 5 responses indicated they increase patient mortality overall.

Item 2 (Figure 2) was a true and false question which stated: “Blood Transfusions are the
most common medical procedure performed in hospitals?” True was the correct response. Preintervention, 6 responses were true, and 4 were false. In the post-intervention questionnaire 8
respondents answered true, and 2 answered false.

Item 3 (Figure 3) was a multiple-choice question which stated: “Which of the following
laboratory profiles is most indicative of iron deficiency anemia?” Answer Choice B “Hgb: 12,
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MCV: 71, Ferritin: 90, Transferrin: 397” was the correct response. Pre-intervention, 3
respondent selected A, 4 correctly selected answer choice B, no respondents selected answer
choice C, and 3 selected answer choice D. In the post-intervention questionnaire, 0 respondents
selected A, 8 correctly selected answer choice B, 1 respondent selected answer choice C, and 1
selected answer choice D.

Item 4 (Figure 4) was a multiple-choice question which stated: “What is the minimum
amount of a time for erythropoietin administration prior to surgery?” Answer Choice D “ 1
month before surgery” was the correct response. Pre-intervention, 1 respondent selected A, 2
selected answer choice B, 4 respondents selected answer choice C, and 2 selected correctly
selected answer choice D, and 1 respondent selected answer choice E. In the post-intervention
questionnaire, 0 respondents selected A, 1 selected answer choice B, 2 respondents selected
answer choice C, 7 selected answer choice D, and no respondents selected answer choice E.
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Item 5 (Figure 5) was a multiple-choice question which stated: “Current guidelines
recommend that patients with cardiovascular comprise should be transfused at what threshold
hemoglobin level?” Answer Choice C “Hgb: 8 g/dL” was the correct response. Pre-intervention,
0 respondents selected A, 5 selected answer choice B, 5 respondents correctly selected answer
choice C, and 0 selected answer choice D. In the post-intervention questionnaire, 0 respondents
selected A, 1 selected answer choice B, 9 respondents selected answer choice C, 0 selected
answer choice D.

Item 6 (Figure 6) was a multiple-choice question which stated: “When should acute
normovolemic hemodilution be initiated in the perioperative period?” Answer Choice B “Before
incision” was the correct response. Pre-intervention, 6 respondents selected A, 3 correctly
selected answer choice B, 1 respondent selected answer choice C, and 0 selected answer choice
D. In the post-intervention questionnaire, 1 respondent selected A, 7 selected answer choice B, 2
respondents selected answer choice C, 0 selected answer choice D
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Item 7 (Figure 7) was a multiple-choice question which stated: “Which of the following
is NOT a benefit of cell savage?” Answer Choice C “Reduced incidence of hypotension” was the
correct response. Pre-intervention, 2 respondents selected A, 0 selected answer choice B, 6
respondent correctly selected answer choice C, and 2 selected answer choice D. In the postintervention questionnaire, 1 respondent selected A, 0 selected answer choice B, 8 respondents
selected answer choice C, 1 selected answer choice D.

Item 8 (Figure 8) was a true and false question which stated: “Arterial Lines increase the
risk of hospital-acquired anemia” True was the correct response. Pre-intervention, 2 responses
were answered true, and 8 were false. In the post-intervention questionnaire 4 respondents
answered true, and 6 answered false.
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Item 9 (Figure 9) was a select all that apply question which stated: “The three pillars of
Patient Blood Management are?” Answers A (Optimization of hematopoiesis), B (Minimize
Blood Loss and Bleeding) , and D (Increasing physiologic tolerance of anemia) were correct.
Pre-intervention, 7 responses stated optimization of hematopoiesis, 9 respondents selected
minimize blood loss and bleeding, 6 responses selected initiation of transfusions before acute
blood loss, 4 responses selected increasing physiologic tolerance of anemia, 4 responses selected
maintenance of normothermia, and 1 response selected reducing hemoglobin transfusion
thresholds. In the post-intervention questionnaire, 10 responses correctly stated optimization of
hematopoiesis, 8 respondents correctly selected minimize blood loss and bleeding, and 8
responses correctly selected increasing physiologic tolerance of anemia.

Item 10 (Figure 10) was a multiple-choice question with multiple answers were possible
which stated: “Which of the following pre-operative treatments for anemia would you offer?”
Pre-intervention, 6 respondents selected A, 8 selected answer choice B, 6 responses were answer
choice C, and 5 selected answer choice D. In the post-intervention questionnaire, 3 respondent
selected A, 10 selected answer choice B, 7 respondents selected answer choice C, 4 selected
answer choice D
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Aggregated pre and post-test results were compiled (Table 2). The pre-test for the
purpose of determining each clinician’s baseline knowledge was delivered prior to the
PowerPoint Presentation and it was identical to the Post-Test at the conclusion of the project.
The post-test was presented after the educational module, and it was meant to determine if any
learning had occurred and if clinicians would willing to implement PBM principles into their
own anesthetic practice. All participants attained a higher score when compared to their
performance on the pre-test. Furthermore, 10 (100%) of clinicians claimed that they would be
willing to apply what they learning into their own practice.

Table 2. Pre and Post Test Results
Participant
#1
#2
#3
#4
#5
#6
#7
#8
#9
#10

Pre-Test Score
4/10 (40%)
5/10 (50%)
3/10 (30%)
2/10 (20%)
5/10 (50%)
1/10 (10%)
3/10 (30%)
6/10 (60)%)
5/10 (50%)
4/10 (40%)

Post-Test Score
8/10 (80%)
10/10 (100%)
7/10 (70%)
8/10 (80%)
6/10 (60%)
10/10 (100%)
9/10 (90%)
9/10 (90%)
9/10 (90%)
10/10 (100%)
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Discussion
The educational modules significant positive results. All participants attained higher
scores on the post-test when compared to the pre-test. On average, outcomes improved by
203.3%. The number of clinicians that would be “willing” to incorporate PBM into their
perioperative management was 100%. Pre-test scores also denote a significant deficit of
knowledge among anesthesia providers regarding Patient Blood Management, highlighting the
need for implementation of patient blood management education and programs. This educational
intervention was able to improve anesthesia provider knowledge and competence in Patient
Blood Management in its limited sample. However, the sample size was small and limited to one
anesthesia group.
Limitations
The most significant limitation of this study is its small sample size of 10 participants. A
total of 40 CRNAs were solicited for participation, and 10 took part of in the study. Another
limitation was that all interaction was web-based. Not only can an email invitation be easily
overlooked, but also there is no guarantee that partakers would complete the online module
without distractions.
Conclusion
The extensive literature review has shown that Patient Blood Management has great
potential to prevent negative sequalae associated with allogenic blood transfusions. However, the
novelty of this multidisciplinary bundle and the state of the current national blood supply denotes
the importance of, and likely knowledge deficit of, PBM among healthcare providers.
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A common barrier cited to implementing PBM protocols is a lack of knowledge and information
among providers The educational module carried out by the author of this scholarly paper
demonstrated that anesthesia providers are willing to learn new ways for the perioperative
management of allogenic blood transfusions. It also demonstrated that they are open to adjusting
their clinical practice in pursuit of the best possible patient outcomes. It is worthwhile to conduct
future research on PBM with a focus on implementation of a PBM program. New standardized
guidelines could help decrease the incidence of morbidity and, and decrease healthcare costs.
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